Concepedia

Andrew C. Allen

AC

Statistics

Publications

32

Citations

1.7K

H-Index

24

Active since

1981

Affiliations

National Institute on Drug Abuse(Current)

Array BioPharma (United States)

Drug Enforcement Administration

New Frontier

National Institutes of Health

Andrew C. Allen is an author at National Institute on Drug Abuse specializing in pharmacology, pharmacy, and medicinal chemistry.

Publications per year

1981–2013

32

Publications

32

An Investigation of Imidazole and Oxazole Syntheses Using Aryl-Substituted TosMIC Reagents<sup>1</sup>

Joseph Sisko, Andrew J. Kassick, Mark Mellinger et al. · The Journal of Organic Chemistry · 2000 · 158 citations

, , +13

Novel 3.alpha.-(Diphenylmethoxy)tropane Analogs: Potent Dopamine Uptake Inhibitors without Cocaine-like Behavioral Profiles

Amy Hauck Newman, Andrew C. Allen, Sari Izenwasser et al. · Journal of Medicinal Chemistry · 1994 · 116 citations · Full text

, , +13

Novel 4'-Substituted and 4',4''-Disubstituted 3.alpha.-(Diphenylmethoxy)tropane Analogs as Potent and Selective Dopamine Uptake Inhibitors

Amy Hauck Newman, Richard H. Kline, Andrew C. Allen et al. · Journal of Medicinal Chemistry · 1995 · 112 citations · Full text

, , +13

Benzylic Oxidation of Gemfibrozil-1-<i>O</i>-β-Glucuronide by P450 2C8 Leads to Heme Alkylation and Irreversible Inhibition

Brian R. Baer, Robert Kirk DeLisle, Andrew C. Allen · Chemical Research in Toxicology · 2009 · 88 citations

, , +17

Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors

C. Todd Eary, Zachary S. Jones, Robert D. Groneberg et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 87 citations · Full text

, , +7

1–5 of 32